"The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections.
Orbactiv is approved to treat patients with acute bacterial skin and skin structure infections (ABSS"...
Information for Patients: See Warnings and Precautions section under Application Instructions.
Pregnancy: WHEN USED FOR THE TREATMENT OF TINEA VERSICOLOR, SELSUN (selenium) IS CLASSIFIED AS PREGNANCY CATEGORY C. Animal reproduction studies have not been conducted with SELSUN (selenium) . It is also not known whether SELSUN (selenium) can cause fetal harm when applied to body surfaces of a pregnant woman or can affect reproduction capacity. Under ordinary circumstances SELSUN (selenium) should not be used for the treatment of tinea versicolor in pregnant women.
Pediatric Use: Safety and effectiveness in infants have not been established.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Selsun Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.